All Episodes
Neuro-Oncology: The Podcast — 144 episodes
A Conversation on Career Journeys with SNO's Young Investigator Committee Chairs
Neuro-onc Narratives: Two Insiders, One Diagnosis: A Neurosurgeon and Healthcare Leader on Living with GBM
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience
Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial
Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma
Author Interview Series SNO Podcast May 2026
Neuro-Oncology Narrative
Hot Topics: Wellness in Neuro-oncology
Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma
Hot Topics: What's next in neuro-oncology
Neuro-Oncology Nugget: Career Development Outreach from SNO
Neuro-onc Narratives: An Interview with Caroline Catlin
Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"
Hot Topics: AYA in Neuro-Oncology
Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma
SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology
Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors
Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG
Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology
Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma
Hot Topics: Clinician-Patient Relationship in Neuro-Oncology
Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma
SNObound: Career Advice from Dr. Gelareh Zadeh
Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma
Hot Topics: Radiation Hypofractionation in Glioma
Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma
Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association
Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma
Hot Topics: How longitudinal profiling of glioma informs therapy development
Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma
SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
Introduction to Neuro-Oncology: The Podcast 2.0
Radiotherapy induced neurocognitive decline
QOL and cognitive functioning in patients with oligodendroglioma
Post-operative radiation in recurrent grade 1 meningiomas
mRNA CAR T against GD2 in high-grade glioma models
A transcriptomic atlas of CNS tumors
Gut microbiome in primary CNS lymphoma
Germline analysis of diffuse midline glioma
The proteomic landscape of diffuse midline glioma
Radio-Pathomic maps and MR perfusion
CSF proteomics in glioma
Vorasidenib in IDH mutant glioma
KL-50 in post TMZ MMR-deficient GBM
Measurable disease per FET-PET vs MRI in GBM
Pre-radiation chemotherapy in GBM
cIMPACT-NOW Update 8: grading of meningiomas
Residual tumor volume and survival after CCNU/TMZ in GBM
Alterations in RNA splicing between meningioma DNA methylation groups
The immune landscape of IDH mutant and IDHwt glioma
Equity-driven applications of AI in neuro-oncology
IDH mutant glioma across age groups
Contemporary molecular prognostic signatures in glioma
FDG PET in PCNSL
TMZ and MGMT in elderly GBM patients
IDH mutant glioma and IDH inhibitors
Leptomeningeal disease, a SNO and ASCO review
Cancer stems cell in GBM
Drug delivery across the blood-brain barrier
Gliomatosis cerebri in children
Immunotherapy drives mesenchymal shift in GBM
Long-term outcomes of pediatric patients with optic pathway glioma
NF1 mutation and neuronal hyperexcitability
Postoperative cerebellar mutism
Cell cycle checkpoints and alkylating agents
Liquid biopsy in CNS lymphoma
Immunotherapy for glioblastoma, lessons learned
TERTp mutation clonality in glioma
Liquid biopsy in H3K27M glioma
Glioma genetic profiles and electrophysiologic hyperexcitability
Epidemiology of glioma in Belgium
The Biology of H3K27M Mutant Gliomas
3D tumor volume assessment in PCNSL
Brain-tumor related epilepsy; a SNO consensus review
Vorasidenib and grading of IDH mutant astrocytoma
Insulin feedback and PI3K inhibition in GBM
SOX10 indel mutations in schwannomas
Dendritic cell vaccines in gliomas
Intrathecal trastuzumab for leptomeningeal metastases
Short term topiramate for radiation induced cytotoxic edema
Venous thromboembolism in gliomas
RANO resect
Methylation profiling of adult ependymoma
Pseudoprogression in IDH-mutant high-grade gliomas
Changes in survival outcomes in melanoma patients with brain metastases
Radiation therapy and structural brain changes
Objective response rate targets for recurrent glioblastoma clinical trials
Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era
Palliative care in neuro-oncology
Nivolumab in MGMT methylated GBM
IDH mutant gliomas; SNO consensus Review
DNA methylation subclass and extent of GBM resection
Pre-operative [11C]methionine PET for low-grade glioma
The role of T lymphocytes in the glioma pathobiology
CDKN2A homozygous deletion in IDH mutant astrocytoma
EGFR: the lazarus target in glioblastom
Brain metastases; a SNO consensus review: Part 2
Brain metastases; a SNO consensus review: Part 1
Pediatric IDH mutant gliomas
Low-risk meningioma: Outcomes from NRG 0539
Selumetinib in children with NF1 and plexiform neurofibroma
Targeted therapy for BRAF-mutant pediatric glioma
Early/evolving IDH wild-type glioblastoma
PI3K signaling in IDH mutant gliomas
Cell-free DNA from CSF in pediatric, adolescent and young adult patients
Molecular determinants of neurocognitive deficits in glioma
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Clinical trial accrual for women and minorities in neuro-oncology
The clinical utility of next generation sequencing for IDHwt glioblastoma
Trabectedin for recurrent grade 2 or 3 meningiomas
Glioblastoma cell heterogeneity and plasticity
Moleculary integrated grading for meningioma
BOLD fMRI in IDH mutant gliomas
Glioblastoma subtypes and response to Dasatinib
Resection for recurrent brain metastases
Incidental Meningiomas
Immunosuppression in IDH mutant gliomas
Immunotherapy for melanoma brain metastases
DNA methylation profiles within the CATNON trial
18F FET PET in childhood CNS tumors
Checkpoint blockade in atypical meningiomas
Molecular signatures of glioma causation
Testing methods for MGMT promoter methylation
Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas
Posterior fossa syndrome
Loss of H3K27me3 in meningiomas
Loss of H3K27me3 in the Tübingen meningioma cohort
A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM
Brain radiotherapy and decline in fine motor skills
A serum based DNA methylation assay to detect gliomas
PTEN deficiency and proteosome addiction in glioblastoma
Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases
The incidence of brain metastases among patients with metastatic breast cancer
Epidemiology of Brainstem High-Grade Gliomas in Children and Adolescents in the United States, 2000-2017
A large longitudinal study of patients with Neurofibromatosis Type 2.
Vorinostat and bevacizumab for recurrent glioblastoma
A subset of pediatric thalamic gliomas
Supratotal resection of lower-grade gliomas
Friends of SNO
Announcing Neuro-Oncology: The Podcast